Table 3: Report of Major Adverse Reactions of Listed Nano-particles.
|
Name of drug |
Active ingredient |
Dosage form route of administration |
Main adverse reactions reported |
|
Doxil® |
Adriamycin |
Injection; Intravenous injection |
Leukopenia (which occurs in nearly half of patients); Nausea, weakness, hair loss, fever, diarrhea, etc (≥ 5%) |
|
Rapamune® |
Sirolimus |
Tablet; Oral |
Thrombocytopenia, anemia, fever, hypertension, etc. (about 10%) |
|
Emend® |
Aprepitant |
Capsule; Oral |
Constipation (7-8%), anorexia (about 3%) |
|
Abraxane® |
Paclitaxel |
Injection; intravenous drip |
Hair loss, neutropenia, ECG abnormalities, muscle joint pain, elevated AST levels, etc. (≥ 20%) |
|
KaiLai® |
Doxorubicin |
Injection; intravenous drip |
Bone marrow suppression |